Moroccan pharma tycoon Lamia Tazi loses more than $15 million from stake in Sothema
Tazi holds a substantial 8.4-percent stake in the leading healthcare company, or 605,030 issued shares.
Sothema
Moroccan businesswoman Lamia Tazi loses nearly $11 million in 2 months
Tazi is one of the most affluent investors on the Casablanca Stock Exchange.
Moroccan tycoon Lamia Tazi set to receive $1.48-million dividend
Tazi holds a substantial 8.4-percent stake in Morocco’s leading healthcare company, Sothema, or 605,030 shares.
Moroccan businesswoman Lamia Tazi’s Sothema records over $27 million in profit in 2022
Tazi owns a significant 8.4-percent stake in Sothema.
Moroccan businesswoman Lamia Tazi gains $10.5 million in two weeks from Sothema shares
Tazi owns a significant 8.4-percent stake in Sothema.
Moroccan pharma mogul Lamia Tazi’s Sothema acquires stake in European startup
The French startup Ziwig is revolutionizing medical diagnostics.
Moroccan tycoon Lamia Tazi gains nearly $4.2 million in 155 days
Tazi is the chairperson and CEO of Sothema.
Moroccan businesswoman Lamia Tazi’s Sothema reveals plan to set up operations in Central Africa
Sothema is Morocco’s leading healthcare firm.
Moroccan businesswoman Lamia Tazi’s Sothema records over $108 million in revenue in H1 2022
Sothema produces more than 60 million units of pharmaceuticals every year.
Moroccan pharmaceutical tycoon Lamia Tazi loses $9.4 million from her stake in Sothema
Tazi owns a sizable 3.93-percent stake in the company, totaling 282,644 shares.
Moroccan businesswoman Lamia Tazi loses $7.1 million from stake in pharmaceutical company, Sothema
Sothema has grown into a leading pharmaceutical company in Africa and the Middle East.
Moroccan businesswoman Lamia Tazi’s Sothema records over $217 million in revenue in 2021
Sothema produces over 60 million units of pharmaceuticals yearly.
Led by wealthy Moroccan Tazi and Berrada families, Sothema posts $14.45 million in H1 profits
The Morocco-based pharmaceutical company specializes in medicine production and sales.
Affluent Moroccan Berrada family earns $118 million from equity stake in Sothema
Alongside the multimillionaire Tazi family, the Berradas own a majority stake in the drug manufacturer.